Impact of circulating tumor DNA (ctDNA) detection on survival outcomes of patients (pts) treated with immune-checkpoint inhibitors (ICIs) in early clinical trials
Galvao, V., Matos, I., Moreno, A., Alonso, G., Brana, I., Villar, M., Felip, E., Tabernero, J., . . . Garralda, … Read More
